RESUMEN
BACKGROUND AND PURPOSE: Atopic dermatitis (AD) is a multifactorial skin condition with complex interactions of innate and adaptive immune responses. There are several existing therapies for AD, including topical glucocorticosteroids, emollients, phototherapies, calcineurin inhibitors and immunosuppressants, such as cyclosporine A. Although these therapies reduce inflammation, they also cause serious side effects. Therefore, it is necessary to develop new therapeutic approaches for AD treatment without side effects. There are several studies on natural materials or toxins, such as herbs, ginseng extract and snake venom, for AD treatment. However, treatment of AD with bee venom and its major component, melittin has rarely been studied. EXPERIMENTAL APPROACH: Effects of bee venom and melittin were studied in a model of AD in vivo induced by 1-chloro-2,4-dinitrobenzene (DNCB) in female Balb/c mice and in cultures of human keratinocytes, stimulated by TNF-α/IFN-γ. The potential pharmacological effects of bee venom and melittin on these in vivo and in vitro AD-like skin disease models were studied. KEY RESULTS: Bee venom and melittin exhibited potent anti-atopic activities, shown by decreased AD-like skin lesions, induced by DNCB in mice. In vitro studies using TNF-α/IFN-γ-stimulated human keratinocytes showed that bee venom and melittin inhibited the increased expression of chemokines, such as CCL17 and CCL22, and pro-inflammatory cytokines, including IL-1ß, IL-6 and IFN-γ, through the blockade of the NF-κB and STAT signalling pathways. CONCLUSIONS AND IMPLICATIONS: Our results suggest that bee venom and melittin would be suitable for epicutaneous application, as topical administration is often appropriate for the treatment of AD.
Asunto(s)
Venenos de Abeja/farmacología , Dermatitis Atópica/tratamiento farmacológico , Meliteno/farmacología , Animales , Diferenciación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Dermatitis Atópica/patología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Técnicas In Vitro , Ratones , Ratones Endogámicos BALB C , Relación Estructura-ActividadRESUMEN
INTRODUCTION: This study inquired into any significant difference in blood lead levels (BLLs) among aircraft maintenance crews at the air-bases, each with a different aviation fuel in use, and confirmed an environmental impact of leaded aviation gasoline (AVGAS). METHODS: This study included a total of 256 male aircraft maintenance personnel, among whom 105 used only AVGAS as their aviation fuel, while 151 used only jet propellant 8 (JP-8), a kerosene variety. BLLs were measured and the data on related factors were obtained. RESULTS: The arithmetic and geometric means of BLLs of the personnel at the airbases that used only AVGAS were 4.20 microg x dl(-1) and 4.01 microg x dl(-1) and that used only JP-8 were 3.79 microg x dl(-1) and 3.57 microg x dl(-1), respectively. The BLLs of the maintenance crew of the main workspace that was located within a 200-m distance from the runway were higher than those of the main workspace that was located 200 m or farther from the runway. The longer the work hours in the runway or the longer the work duration, the higher the BLLs of the maintenance crew. DISCUSSION: This investigation exposed the fact that a body's BLL could be increased by AVGAS emissions through the examination of aircraft maintenance crew. This result is in agreement with results of previous studies that suggest proximity to an airport may be associated with elevated BLLs for adults and children. Collectively, the results of the current study and previous research suggest that long-duration inhabitation and/or activities in close proximity to an air facility should be limited given that lead poses known health risks.